166 related articles for article (PubMed ID: 19967453)
1. FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.
Dongsong N; Zhou JY
Mol Biol Rep; 2010 Oct; 37(7):3473-80. PubMed ID: 19967453
[TBL] [Abstract][Full Text] [Related]
2. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.
Hosokawa Y; Arnold A
Genes Chromosomes Cancer; 1998 May; 22(1):66-71. PubMed ID: 9591636
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 gene amplification is highly homogeneous in breast cancer.
Burandt E; Grünert M; Lebeau A; Choschzick M; Quaas A; Jänicke F; Müller V; Scholz U; Bokemeyer C; Petersen C; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Wilczak W
Breast Cancer; 2016 Jan; 23(1):111-119. PubMed ID: 24862872
[TBL] [Abstract][Full Text] [Related]
7. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
Bautista S; Theillet C
Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
9. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
[TBL] [Abstract][Full Text] [Related]
10. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
[TBL] [Abstract][Full Text] [Related]
12. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
13. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.
Dickson C; Fantl V; Gillett C; Brookes S; Bartek J; Smith R; Fisher C; Barnes D; Peters G
Cancer Lett; 1995 Mar; 90(1):43-50. PubMed ID: 7720042
[TBL] [Abstract][Full Text] [Related]
14. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
Reis-Filho JS; Savage K; Lambros MB; James M; Steele D; Jones RL; Dowsett M
Mod Pathol; 2006 Jul; 19(7):999-1009. PubMed ID: 16648863
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors.
Han EK; Lim JT; Arber N; Rubin MA; Xing WQ; Weinstein IB
Prostate; 1998 May; 35(2):95-101. PubMed ID: 9568672
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
[TBL] [Abstract][Full Text] [Related]
18. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
[TBL] [Abstract][Full Text] [Related]
19. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.
Simpson JF; Quan DE; O'Malley F; Odom-Maryon T; Clarke PE
Am J Pathol; 1997 Jul; 151(1):161-8. PubMed ID: 9212742
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in patients with multiple myeloma.
Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B
Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
